The healthcare marketing landscape is undergoing a transformation, and with it comes a set of challenges and opportunities that demand agility, creativity and foresight.

Novo Nordisk is licensing a drug called LX9851 from Lexicon Pharmaceuticals for up to $75 million in upfront and near-term ...

The agency launched its Neurodiversity Center of Excellence to help implement neurodivergent talent in its creative marketing and brand strategy.

Medical marketers, ad agencies, physicians and pharma executives gathered for MM+M’s annual Transform conference, held at One ...